Non-drug evidence map · Supplements and nutraceuticals

Melatonin

81 registered trials across 35 conditions, from ClinicalTrials.gov.

Melatonin taken as a supplement. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

81registered trials
35conditions
32completed
13with results posted
9recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Insomnia
Show trials
113 12 10255
Breast Cancer
Show trials
74 10 7100
Parkinson Disease
Show trials
60 01 5100
Anxiety
Show trials
52 11 4407
Cancer
Show trials
52 11 5169
Schizophrenia
Show trials
53 00 4407
Attention Deficit-Hyperactivity Disorder
Show trials
42 20 446
Migraine Disorder
Show trials
42 21 4192
Epilepsy
Show trials
32 20 3147
Ischemic Stroke
Show trials
30 01 3130
Sepsis
Show trials
31 00 2110
Atopic Eczema
Show trials
21 00 2130
Bipolar Disorder
Show trials
21 01 286
Melanoma
Show trials
20 01 2100
Multiple Sclerosis
Show trials
21 00 234
Obesity
Show trials
20 10 2120
Obstructive Sleep Apnea
Show trials
21 00 220
Polycystic Ovary Syndrome
Show trials
21 00 040
Pulmonary Arterial Hypertension
Show trials
22 00 280
Type 2 Diabetes Mellitus
Show trials
20 00 260
Amyotrophic Lateral Sclerosis
Show trials
11 10 150
Atrial Fibrillation
Show trials
10 00 10
Benign Prostatic Hyperplasia
Show trials
10 00 1104
Cervical Cancer
Show trials
11 00 184
Gastroesophageal Reflux Disease
Show trials
10 00 1150
Glaucoma
Show trials
11 00 164
Heart Failure
Show trials
10 00 10
Huntington Disease
Show trials
11 00 115
Inflammatory Bowel Disease
Show trials
10 01 190
Long COVID
Show trials
11 00 1830
Lung Cancer
Show trials
11 10 182
Osteoarthritis
Show trials
11 00 1340
Postural Orthostatic Tachycardia Syndrome
Show trials
10 00 0150
Systemic Lupus Erythematosus
Show trials
10 00 164
Type 1 Diabetes Mellitus
Show trials
10 00 030

What these trials measure

Primary outcomes, grouped by keyword rules: Sleep (24), Symptom severity and disease activity (18), Inflammation and other biomarkers (9), Clinical events, survival and healthcare use (8), Mood, anxiety and wellbeing (5), Pain (5), Heart rate, blood pressure and autonomic (4), Feasibility, adherence and safety (4), Cognition (4), Breathing and lung function (2), Physical function and exercise capacity (2), Weight and metabolic markers (2), Fatigue and energy (1), Quality of life (1).

Names used for this class in the registry

melatonin, inhaled melatonin (100 μg), melatonin(circadin®), melatonin (n-acetyl-5-methoxytryptamine), melatonin patches, group 3: melatonin group, therapeutic melatonin, melatonin oral gel 3%, experimental: melatonin treatment group, melatonin ("circadin"), low dose melatonin, high dose melatonin

Download all 81 trials (CSV) All non-drug classes

Related in Supplements and nutraceuticals: Vitamin D · Omega-3 fatty acids and fish oil · Probiotics, prebiotics and synbiotics · Coenzyme Q10 · NAD+ precursors (nicotinamide riboside, NMN) · N-acetylcysteine · Magnesium · Zinc · Creatine · Vitamin C · B vitamins and folate · Curcumin and other polyphenols · Amino acids and protein supplements · Herbal medicines and traditional formulas · Other vitamins, minerals and multivitamins · Other supplements and nutraceuticals

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.